AFB holds EUR 86m first close for second fund

  • by

Advent France Biotechnology (AFB) has held a EUR 86m first close for its second fund, which will continue the firm’s focus on European early-stage life sciences investments.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *